Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Obstet Gynecol. 2022 Jan 1;139(1):21–30. doi: 10.1097/AOG.0000000000004632

Table 1.

Maternal and study characteristics of exposure by cotinine and THC-COOH

Cotinine THC-COOH
Positive Negative P-value Positive Negative P-value
N=99 N=1098 N=47 N=1150
Maternal age (years) 26.6 ±5.9 27.8 ±5.7 0.05 26.1 ±6.1 27.8 ±5.7 0.04
Maternal BMI (kg/m 2 ) 30.0 ±8.0 29.0 ±6.5 0.47 29.3 ±8.1 29.0 ±6.6 0.65
Education <0.001 0.003
 Less than high
 school
33 (33) 498 (45) 20 (43) 511 (44)
 High school 61 (62) 354 (32) 25 (53) 390 (34)
 College 5 (5) 246 (22) 2 (4) 249 (22)
Married/partner 41 (41) 838 (76) <0.001 21 (45) 858 (75) <0.001
Private insurance 13 (13) 325 (30) <0.001 3 (6) 335 (29) <0.001
Race or ethnicity <0.001 <0.001
 Black 41 (41) 136 (12) 21 (45) 156 (14)
 Hispanic 11 (11) 621 (57) 5 (11) 627 (55)
 Other* 2 (2) 23 (2) 2 (4) 23 (2)
 White 45 (46) 318 (29) 19 (40) 344 (30)
Gestational age at randomization & urine sample (weeks) 17.4 ± 3.0 17.1 ±3.0 0.21 17.5 ±2.9 17.1 ±3.0 0.34
Gestational age at delivery (weeks) 38.1 ±4.7 39.0 ±2.6 0.42 38.5 ±4.4 39.0 ±2.7 0.30
Levothyroxine Treatment group 47 (48) 554 (51) 0.57 25 (53) 576 (50) 0.68
Thyroid status <0.001 <0.001
 Subclinical hypothyroxinemia 27 (27) 647 (59) 9 (19) 665 (58)
 Subclinical hypothyroidism 72 (73) 451 (41) 38 (81) 485 (42)
*

Includes Asian, American Indian and participant-selected “other” category for race.